Compare Indofarma Tbk. (INAF) vs Mandala Multifinance Tbk. (MFIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indofarma Tbk. vs Mandala Multifinance Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Mandala Multifinance Tbk. trades at Rp890 (market cap 4.45T). The key difference: Mandala Multifinance Tbk. is far larger — about 11.4× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | MFIN | |
|---|---|---|
Market Cap | 390.51B | 4.45T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →About Mandala Multifinance Tbk.
PT Mandala Multifinance Tbk (the Company) was established under its original name of PT Vidya Cipta Leasing Corporation on Aug 13th, 1983, then changed to PT Lautan Berlian Leasing at 1990. On 1996 company's name changed to PT Gracia Dinamika Mulifinance and in 1997 the name changed to PT Mandala Multifinance.The articles of association has been amended most recently by notarial deed no 34 dated 28 Apr 2005 concerning among others, the change in the company's name and public offering of stock.
Read more on MFIN →
